This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2022.
Company Filing History:
1 out of 834,411 Years Active: 2022
Title: Lingzi Hong: Innovator in IL-17a Related Treatments
Introduction
Lingzi Hong is a notable inventor based in Cleveland Heights, OH (US). He has made significant contributions to the field of medical research, particularly in the treatment of IL-17a related diseases and conditions. His innovative work has the potential to impact many lives positively.
Latest Patents
Lingzi Hong holds a patent for "SBE aptamers for treating IL-17a related diseases and conditions." This patent includes compositions, systems, kits, and methods that utilize an SBE nucleic acid sequence to bind a SEFIR domain of an ACT1 protein. This innovative approach aims to provide new therapeutic options for patients suffering from these conditions. He has 1 patent to his name.
Career Highlights
Throughout his career, Lingzi Hong has focused on developing advanced solutions for complex medical issues. His dedication to research and innovation has established him as a respected figure in his field. His work continues to inspire others in the medical and scientific communities.
Collaborations
Lingzi has collaborated with talented individuals such as Xiaoxia Li and Tomasz Herjan. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Lingzi Hong's contributions to the field of IL-17a related treatments exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for improving patient outcomes.